FOXA1 and endometrial cancer: The higher expression of FOXA1 in metastases compared to their primary tumor counterparts, and the association between protein expression of FOXA1 and CDKN2A mRNA only in metastatic lesions, may indicate a change in the role of FOXA1 during endometrial cancer progression.